West Pharmaceutical Services (WST) Stock Price, Quote & News

Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applicati...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 610 594 2900

Website: www.westpharma.com

Address:

530 Herman O. West Drive, Exton, United States

RunnerSignals Jan. 25 at 9:48 PM

$BHC $ORI $SHOP $NTNX $WST screaming oversold fear or opportunity? see which ones might bounce first https://stocksrunner.com/news/2026-01-25-identify-oversold-stocks-and-potential-reversals

0 · Reply

ZacksResearch Jan. 23 at 7:43 PM

West Pharma unveils a new syringe — small launch, big implications? 💉 $WST just debuted the Synchrony S1 prefillable syringe at Pharmapack 2026, designed to enhance support for biologics, vaccines, and home-care applications. Could this product deepen its positioning in high-growth therapies? Full details here 👉 https://www.zacks.com/stock/news/2822215/wst-launches-synchrony-s1-prefillable-syringe-at-pharmapack?cid=sm-stocktwits-2-2822215-teaser-30289&ADID=SYND_STOCKTWITS_TWEET_2_2822215_TEASER_30289

0 · Reply

AStrokeOfLuck Jan. 23 at 7:24 PM

$NVO $BDX $WST

1 · Reply

ZacksResearch Jan. 23 at 6:43 PM

$WST unveils Synchrony S1 syringe system, but shares dip 1.1%. Why? 🤔 🧪 Supports biologics & vaccines, aligning with combo products & home care trends 📉 Yet, stock down 11.2% in 6 months, lagging industry & S&P 500 growth Discover why this innovation could be a long-term driver for $WST 👉 https://www.zacks.com/stock/news/2822215/wst-launches-synchrony-s1-prefillable-syringe-at-pharmapack?cid=sm-stocktwits-2-2822215-body-30281&ADID=SYND_STOCKTWITS_TWEET_2_2822215_BODY_30281

0 · Reply

Arcides Jan. 16 at 9:26 PM

$WST breakdown with a lot of volume..next level of interest 239

0 · Reply

ZacksResearch Jan. 14 at 6:12 PM

$WST is heating up — but it’s not a one-way trade. 👀 Surging GLP-1 demand and HVP expansion are powering the bull case, even as pricing pressure, tariff risks, and contract manufacturing headwinds cloud the near-term outlook. ⚠️ Full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2817573/reasons-to-add-west-pharmaceutical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2817573-teaser-28954&ADID=SYND_STOCKTWITS_TWEET_2_2817573_TEASER_28954

0 · Reply

ZacksResearch Jan. 14 at 5:12 PM

$WST up 21.1% in 6 months compared to industry's 0.8% return — what's driving the momentum? 🚀 🌟 Strong demand for GLP-1 therapies & Annex 1 regulatory upgrades 📈 13% organic growth in high-value product components 🔍 Zacks Rank #2 with a trailing 4-quarter earnings surprise of 15.52% Discover the full growth story here 👉 https://www.zacks.com/stock/news/2817573/reasons-to-add-west-pharmaceutical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2817573-body-28955&ADID=SYND_STOCKTWITS_TWEET_2_2817573_BODY_28955

0 · Reply

ZacksResearch Dec. 11 at 2:31 PM

Is $WST poised for a comeback despite a rough start in 2023? 📉 The stock is down 18.5% YTD, but with a Zacks Rank #3 and a robust GLP-1 demand, WST is positioned for growth despite challenges like pricing headwinds and tariff risks. HVP components rose 13% organically, and free cash flow is up 54% YTD due to capital discipline and improved supply-chain efficiencies, indicating strong underlying momentum. 🚀 Explore the full analysis here 👉 https://www.zacks.com/stock/news/2802781/reasons-to-retain-west-pharmaceutical-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2802781-body-24365&ADID=SYND_STOCKTWITS_TWEET_2_2802781_BODY_24365

0 · Reply

ZacksResearch Dec. 11 at 1:31 PM

Is $WST quietly setting up for a rebound play? The teaser says strong HVP demand, rising GLP-1 exposure, and Annex 1 tailwinds are all working in its favor, even though pricing and device margins are pressuring the near-term picture. Full breakdown here 👉 https://www.zacks.com/stock/news/2802781/reasons-to-retain-west-pharmaceutical-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2802781-teaser-24364&ADID=SYND_STOCKTWITS_TWEET_2_2802781_TEASER_24364

0 · Reply

BillionerOfKing Dec. 3 at 9:36 AM

$WST Current Stock Price: $272.95 Contracts to trade: $270 WST Dec 19 2025 Call Entry: $8.10 Exit: $10.61 ROI: 31% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

West to Host Fourth-Quarter and Full-Year 2025 Conference Call

Jan 26, 2026, 10:00 AM EST - 7 days ago

Time To Buy The Dip In West Pharmaceutical Stock?

Jan 25, 2026, 10:09 AM EST - 8 days ago

Conestoga Mid Cap Composite Q4 2025 Leaders And Laggards

BSY CSGP GNRC IDXX JKHY POOL RGEN

Jan 20, 2026, 6:00 AM EST - 14 days ago

West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack

Jan 14, 2026, 3:45 PM EST - 19 days ago

West Pharmaceutical Services, Inc. (WST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 6:00 AM EST - 22 days ago

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States

ABBV

Jan 12, 2026, 6:00 AM EST - 22 days ago

West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie

ABBV

Dec 31, 2025, 8:47 AM EST - 4 weeks ago

Best Dividend Aristocrats For January 2026

ABBV ABT ADM ADP AFL ALB AMCR

Dec 12, 2025, 6:00 AM EST - 7 weeks ago

West to Participate in Upcoming Investor Conference

Dec 10, 2025, 6:00 AM EST - 7 weeks ago

West Declares Quarterly Dividend

Dec 8, 2025, 9:03 PM EST - 2 months ago

Top 50 High-Quality Dividend Growth Stocks For December 2025

ACN ALLE APH DHI DPZ FDS GGG

Dec 2, 2025, 5:13 PM EST - 2 months ago

West Pharmaceutical Services, Inc. (WST) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 1, 2025, 3:54 AM EST - 2 months ago

West Pharmaceutical: Back To Growth

Nov 29, 2025, 8:02 AM EST - 2 months ago

Best Dividend Aristocrats For December 2025

ABBV ABT ADM ADP AFL ALB AMCR

Nov 20, 2025, 2:43 PM EST - 2 months ago

West Pharmaceutical Services, Inc. (WST) Presents at Stephens Annual Investment Conference 2025 Transcript

Nov 18, 2025, 7:18 AM EST - 2 months ago

West Pharmaceutical Services, Inc. (WST) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 17, 2025, 11:24 AM EST - 2 months ago

These stocks have been hit hard in 2025 but could surge by as much as 57% from here

ADBE ALGN BLDR CARR CMG CPRT CRM

Nov 11, 2025, 12:21 PM EST - 2 months ago

West Pharmaceutical Services, Inc. (WST) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 6, 2025, 8:10 AM EST - 3 months ago

Artisan Global Opportunities Fund Q3 2025 Portfolio Update

AMZN BSX DKS INSM LHX SPOT TEAM

Oct 27, 2025, 6:00 AM EDT - 3 months ago

West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery

Oct 24, 2025, 6:00 AM EDT - 3 months ago

West to Participate in Upcoming Investor Conferences

Oct 23, 2025, 3:07 PM EDT - 3 months ago

West Pharmaceutical Services, Inc. (WST) Q3 2025 Earnings Call Transcript

Oct 23, 2025, 12:16 PM EDT - 3 months ago

West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand

Oct 23, 2025, 6:52 AM EDT - 3 months ago

West Pharma boosts annual profit forecast on strong demand for its drug components

Oct 23, 2025, 6:00 AM EDT - 3 months ago

West Reports Third-Quarter 2025 Results

Oct 21, 2025, 5:57 AM EDT - 3 months ago

West Pharmaceutical Services: HVP Moat Cum GLP-1 And Biologics Tailwinds Reinforce Upward Momentum

Oct 9, 2025, 6:00 AM EDT - 4 months ago

West to Host Third-Quarter 2025 Conference Call

Oct 3, 2025, 10:46 AM EDT - 4 months ago

Top 50 High-Quality Dividend Growth Stocks For October 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Oct 1, 2025, 10:58 PM EDT - 4 months ago

Top 15 High-Growth Dividend Stocks For October 2025

ACN DPZ EOG FDX INTU MSCI NDSN

Sep 24, 2025, 3:27 PM EDT - 4 months ago

West Pharmaceutical Services, Inc. (WST) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Sep 6, 2025, 12:18 PM EDT - 5 months ago

Top 50 High-Quality Dividend Stocks For September 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Sep 3, 2025, 5:11 PM EDT - 5 months ago

West Pharmaceutical Services, Inc. (WST) Presents At Wells Fargo 2025 Healthcare Conference (Transcript)

Aug 27, 2025, 2:09 PM EDT - 5 months ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR

Aug 21, 2025, 6:00 AM EDT - 5 months ago

West to Participate in Upcoming Investor Conferences in September 2025

Aug 6, 2025, 11:50 AM EDT - 6 months ago

Top 50 High-Quality Dividend Stocks For August 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Jul 30, 2025, 12:20 PM EDT - 6 months ago

West Pharmaceutical: Q2 Earnings Suggest Recovery

Jul 27, 2025, 1:52 AM EDT - 6 months ago

West Pharmaceutical Services: Low Debt, High Profit, And A Waning Destocking Problem

Jul 24, 2025, 1:58 PM EDT - 6 months ago

West Pharmaceutical Services, Inc. (WST) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 10:38 AM EDT - 6 months ago

West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars

Jul 24, 2025, 8:02 AM EDT - 6 months ago

West Pharma raises annual profit forecast on strong demand for its drug components

Jul 24, 2025, 6:00 AM EDT - 6 months ago

West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance

Jul 21, 2025, 6:00 AM EDT - 7 months ago

West Welcomes Robert McMahon as Incoming Chief Financial Officer

Jul 8, 2025, 6:00 AM EDT - 7 months ago

West to Host Second-Quarter 2025 Conference Call

Jul 7, 2025, 2:23 AM EDT - 7 months ago

WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST

Jul 6, 2025, 8:25 AM EDT - 7 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services

Jul 3, 2025, 8:15 AM EDT - 7 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services

RunnerSignals Jan. 25 at 9:48 PM

$BHC $ORI $SHOP $NTNX $WST screaming oversold fear or opportunity? see which ones might bounce first https://stocksrunner.com/news/2026-01-25-identify-oversold-stocks-and-potential-reversals

0 · Reply

ZacksResearch Jan. 23 at 7:43 PM

0 · Reply

AStrokeOfLuck Jan. 23 at 7:24 PM

$NVO $BDX $WST

1 · Reply

ZacksResearch Jan. 23 at 6:43 PM

0 · Reply

Arcides Jan. 16 at 9:26 PM

$WST breakdown with a lot of volume..next level of interest 239

0 · Reply

ZacksResearch Jan. 14 at 6:12 PM

0 · Reply

ZacksResearch Jan. 14 at 5:12 PM

0 · Reply

ZacksResearch Dec. 11 at 2:31 PM

0 · Reply

ZacksResearch Dec. 11 at 1:31 PM

0 · Reply

BillionerOfKing Dec. 3 at 9:36 AM

0 · Reply

BioTechHealthX Dec. 3 at 1:24 AM

$WST Analysts expect strong future earnings from West Pharmaceutical Services (NYSE:WST) due to high-value product expansion, GLP-1 demand, and operational efficiencies. See why this $350.77 price target could be achievable sooner than the market believes. https://biotechhealthx.com/biotech-news/west-pharmaceutical-services-wst-could-outperform-as-analysts-project-350-77-price-target/

0 · Reply

JarvisFlow Dec. 2 at 6:06 PM

Morgan Stanley has updated their rating for West Pharmaceutical Servs ( $WST ) to Equal-Weight with a price target of 285.

0 · Reply

Sean29md Nov. 28 at 2:18 PM

$WST another clue from Halozyme’s patent filings: Halozyme cannot be filing for these patents without knowledge/consent of Sanofi and Regeneron. This is strong indicator of a potential new Enhanze deal with Sanofi/Regeneron https://www.freepatentsonline.com/WO2025245354A1.html https://patentscope.wipo.int/search/en/WO2025245354

0 · Reply

OfficialStocktwitsUser Nov. 25 at 1:53 PM

$WST RSI: 39.40, MACD: -1.9966 Vol: 9.28, MA20: 273.06, MA50: 269.47 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Market Cap	16.63B
Revenue (ttm)	2.89B
Net Income (ttm)	492.70M
EPS (ttm)	N/A
PE Ratio	32.91
Forward PE	30.31
Profit Margin	17.03%
Debt to Equity Ratio	0.07

Volume	1,203,400
Avg Vol	821,818
Day's Range	N/A - N/A
Shares Out	71.94M
Stochastic %K	39%
Beta	1.17
Analysts	Strong Sell
Price Target	$346.43